AGR2 and cancer: In total, 19 signaling pathways were identified, with pathways in cancer and proteoglycans in cancer as the two most prominent hits, indicating that AGR2 downregulation and TGF-β exposure, either alone or combined, provide protumoric and prometastatic signals (Table S2).